-+ 0.00%
-+ 0.00%
-+ 0.00%

Agios Pharmaceuticals Q1 EPS $(1.55) Beats $(1.80) Estimate, Sales $8.73M Miss $9.64M Estimate

Benzinga·05/01/2025 10:34:40
Listen to the news
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.55) per share which beat the analyst consensus estimate of $(1.80) by 13.89 percent. This is a 6.9 percent decrease over losses of $(1.45) per share from the same period last year. The company reported quarterly sales of $8.73 million which missed the analyst consensus estimate of $9.64 million by 9.48 percent. This is a 6.56 percent increase over sales of $8.19 million the same period last year.